福瑞医科(300049.SZ)：预计2025年归母净利润同比增长19.17%-44.77%

Core Viewpoint - The company, Furu Medical (300049.SZ), projects a net profit attributable to shareholders of 135 million to 164 million yuan for 2025, reflecting a year-on-year change of 19.17% to 44.77% [1] Group 1: Financial Projections - For 2025, the medical device business of the French subsidiary is expected to achieve revenue of approximately 1.05 billion to 1.2 billion yuan, with a year-on-year growth of about 13.77% to 30.02% [1] - The net profit from the medical device business is projected to be around 220 million to 260 million yuan, representing a year-on-year increase of approximately 15.48% to 36.47% [1] - The net profit attributable to shareholders from the medical device business is estimated to be about 110 million to 130 million yuan, showing a year-on-year growth of approximately 15.27% to 36.23% [1] Group 2: Other Business Segments - The company plans to adhere to a managed care strategy, with revenue from pharmaceuticals, medical services, and other businesses expected to be around 450 million to 480 million yuan, leading to a net profit attributable to shareholders of approximately 25 million to 34 million yuan [1] - The impact of non-recurring gains and losses on net profit is anticipated to be in the range of -2 million to -8 million yuan for 2025 [1]